Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
opioid save search
Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results For Gross and Net Sales for ZTlido® for the First Quarter 2024; Implements Planned 2024 Commercial Ramp for Additional Opioid Sparing Product and Reduction of R&D and Other Administrative Expenses
Published: 2024-04-16 (Crawled : 13:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: -1.56%
H: 0.0%
C: -7.94%
ztlido sales first company opioid for commercial financial results
Robbins Geller Rudman & Dowd LLP, Lieff Cabraser Heimann & Bernstein LLP, and Dugan Law Firm, APLC Announce a $78 Million Class Action Settlement for Third Party Payors That Paid or Reimbursed Costs for Prescription Opioids or Treatment Related to Opioid Misuse, Addiction, and/or Overdose
Published: 2024-04-15 (Crawled : 20:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: -2.09%
H: 0.0%
C: 0.0%
opioid million treatment for
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
Published: 2024-03-28 (Crawled : 12:00) - globenewswire.com
EBS | $1.86 -2.11% -1.61% 1.1M
|
Health Technology
|
| O: 3.47%
H: 0.0%
C: 0.0%
narcan opioid save ongoing spray
Indivior Announces Publication Demonstrating that OPVEE® (nalmefene) Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone
Published: 2024-03-11 (Crawled : 19:00) - prnewswire.com
INVVY | $21.8455 19.02% 8.1K
|
n/a
| Email alert
Add to watchlist
opvee respiratory depression publication spray study
SciSparc Issued Canadian Patent for Opioids Reduction Use in Pain Management Technology
Published: 2024-03-06 (Crawled : 22:00) - globenewswire.com
SPRC | $1.29 -2.27% -2.33% 140K
|
Manufacturing
|
| O: 6.98%
H: 0.85%
C: -6.01%
management patent technology
Scilex Holding Company Launches New Website to Showcase Growing Portfolio of Non-Opioid Products and Pipeline Information Updates
Published: 2024-03-04 (Crawled : 14:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: 3.37%
H: 2.17%
C: -2.9%
company pipeline growing
Ensysce Biosciences Announces Successful Meeting with FDA for PF614-MPAR, a Next Generation Opioid with Overdose Protection
Published: 2024-02-21 (Crawled : 15:30) - biospace.com/
ENSC | $0.5805 -7.83% -8.49% 90K
|
Health Technology
|
| O: 1.07%
H: 2.5%
C: -3.12%
pf614 fda opioid meeting
RespireRx Pharmaceuticals Inc. Reports Preclinical Pain Relief for their Non-Opioid Lead GABAkine
Published: 2024-02-13 (Crawled : 13:30) - globenewswire.com
RSPI | $0.0009 0.0% 5M
|
Manufacturing
|
| O: -14.29%
H: 33.33%
C: 25.0%
pharmaceuticals preclinical
Heron Therapeutics Announces Partnership with CrossLink Life Sciences to Expand Promotional Effort for ZYNRELEF®, the First and Only Non-Opioid Dual Acting Local Anesthetic for Post-Operative Pain
Published: 2024-01-07 (Crawled : 00:00) - prnewswire.com
HRTX | $2.71 -2.17% -2.21% 1.8M
|
Health Technology
|
| O: 10.73%
H: 8.16%
C: 6.63%
zynrelef partnership first life sciences therapeutics
Scilex Holding Company Announces that According to Prescription Data from Symphony Health, ZTlido® is the Most Prescribed Non-Opioid Branded Pain Treatment By Pain Specialists
Published: 2023-12-20 (Crawled : 14:00) - globenewswire.com
SCLX | $0.8942 -23.57% -30.84% 2.8M
|
|
| O: 3.57%
H: 2.07%
C: -10.34%
ztlido company symphony treatment
AmacaThera Closes Series A Extension to Advance Clinical Development of Long Acting, Localized, Non-Opioid Therapeutics to Improve Post-Surgery Patient Care
Published: 2023-11-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
series care extension therapeutics
US Nuclear Advances Fight Against Opioid Crisis With Breakthrough Fentanyl Detection Technology
Published: 2023-11-15 (Crawled : 14:00) - globenewswire.com
UCLE | $0.0548 218.42% 150K
|
|
| O: 4.58%
H: 15.0%
C: 10.25%
opioid nuclear technology
Opioid Market Forecast: In-depth Analysis Predicts Continued Growth to $25.3 Billion by 2030
Published: 2023-11-14 (Crawled : 02:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.17%
H: 0.0%
C: 0.0%
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
SNY | News | $45.395 -1.55% -1.58% 4.4M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
opioid growth market
BioXcel Therapeutics Announces Update on NIDA-funded Trial of BXCL501 (sublingual dexmedetomidine) for Potential Treatment of Opioid Use Disorder (OUD)
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
BTAI | $2.56 -1.16% -1.17% 240K
|
Health Technology
|
| O: 3.88%
H: 3.11%
C: -0.62%
bxcl501 opioid update treatment trial therapeutics potential
SciSparc Granted Patent from the Australian Patent Office for its Reduction of Opioids Use in Pain Management Technology
Published: 2023-10-31 (Crawled : 12:00) - globenewswire.com
SPRC | $1.29 -2.27% -2.33% 140K
|
Manufacturing
|
| O: 81.23%
H: 7.44%
C: -9.06%
management patent granted technology
Emergent BioSolutions Partners with Emmitt Smith to Launch Ready to Rescue Campaign to Help Save Lives Amidst Rising Opioid Epidemic
Published: 2023-10-16 (Crawled : 11:00) - prnewswire.com
EBS | $1.86 -2.11% -1.61% 1.1M
|
Health Technology
|
| O: 0.79%
H: 0.72%
C: -2.76%
opioid save ready
Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
HROW | $10.84 -8.29% -9.04% 350K
|
Health Technology
|
| O: -0.07%
H: 0.47%
C: -5.14%
melt-300 zydis license pharmaceuticals technology agreement
Emergent BioSolutions’ NARCAN® Nasal Spray Launches Over the Counter Making it Possible for Everyone to Help Save a Life from an Opioid Overdose Emergency
Published: 2023-08-30 (Crawled : 10:00) - globenewswire.com
EBS | $1.86 -2.11% -1.61% 1.1M
|
Health Technology
|
| O: 3.93%
H: 8.75%
C: 7.33%
narcan opioid life save spray
Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations
Published: 2023-08-28 (Crawled : 05:00) - prnewswire.com
MNKPF | $17.25
|
n/a
| Email alert
Add to watchlist
MNK | $0.3402 -0.06% 540K
|
n/a
| Email alert
Add to watchlist
MNKKQ | $0.02
|
Manufacturing
| Email alert
Add to watchlist
opioid financial
BioCorRx Submits Expanded Access Treatment Protocol to FDA for BICX104, Implantable Biodegradable Naltrexone Pellet for Treatment of Opioid Use Disorder
Published: 2023-08-15 (Crawled : 13:00) - globenewswire.com
BICX | $1.47 201.91% 200
|
Health Care and Social Assistan...
|
| O: 15.85%
H: 0.0%
C: 0.0%
bicx104 fda opioid treatment
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.